The first study reported that immediate treatment with edaravone (15 mg/kg/day) after disease onset delayed progression of motor symptoms and motor neuron degeneration in mutant SOD1 (G93A)-transgenic mice [27]. The gene discussed is SOD1; the disease is Motor neuron atrophy.